GlassScriptPhysician profile
Costy S Mattar
NPI 1780860411
$11,049.57
in general payments reported to CMS, 2019-2025
38 companies · $1,173 in 2025
The $1,173 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,121 · 2020: $243 · 2021: $157 · 2022: $973 · 2023: $1,052 · 2024: $6,332 · 2025: $1,173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,048 · Travel and Lodging: $3,509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,048.23 |
| Travel and Lodging | $3,508.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,276.53 | 2021-2025 | Micra, Linq II, Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $2,324.15 | 2022-2025 | Aveir, Merlin@Home, Gallant |
| Novartis Pharmaceuticals Corporation | $466.81 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $418.05 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $369.74 | 2022-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $362.36 | 2020-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $319.26 | 2019-2024 | Farxiga, Andexxa, Imfinzi |
| Amgen INC. | $293.47 | 2019-2025 | Repatha, Repatha |
| Medtronic Vascular, INC. | $270.43 | 2019-2020 | |
| Pfizer INC. | $253.82 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $223.83 | 2019-2022 | |
| Astellas Pharma US INC | $223.18 | 2019 | |
| Daiichi Sankyo INC. | $149.96 | 2022-2025 | Injectafer |
| Actelion Pharmaceuticals US, INC. | $107.81 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Inari Medical, INC. | $98.96 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.60 | 2022-2024 | Jardiance |
| Lantheus Medical Imaging, INC. | $87.15 | 2020-2023 | Definity |
| Cvrx, INC. | $85.52 | 2022-2024 | Barostim Neo System |
| Shockwave Medical, INC | $77.09 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $61.69 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $51.75 | 2019 | |
| Stryker Corporation | $48.10 | 2025 | Artix Mt |
| Penumbra, INC. | $47.54 | 2022-2025 | Penumbra System |
| Boston Scientific Corporation | $46.84 | 2019-2022 | |
| Kestra Medical Technology Services, INC. | $34.19 | 2025 | Assure Wcd |
| Amarin Pharma, INC. | $32.40 | 2019-2020 | |
| Kiniksa Pharmaceuticals International, Plc | $31.51 | 2024 | Arcalyst |
| Surmodics, INC. | $24.82 | 2023 | Pounce Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Radial Access 018 Rx Pta Dilatation Catheter |
| United Therapeutics Corporation | $19.34 | 2025 | |
| Portola Pharmaceuticals, LLC | $18.10 | 2019 | |
| Cardiovascular Systems INC. | $17.81 | 2021 | |
| Angiodynamics, INC. | $17.59 | 2022 | |
| Canon Medical Systems USA, INC. | $17.35 | 2022 | |
| Coala Life INC | $16.51 | 2021 | |
| Chiesi USA, INC. | $16.24 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.13 | 2025 | |
| Philips North America LLC | $16.07 | 2024 | (Ck4) Mcot |
| Sanofi-Aventis U.S. LLC | $12.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Costy Mattar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.